Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer (Q57909007)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 July 2011
edit
Language Label Description Also known as
English
Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer
scientific article published on 25 July 2011

    Statements

    Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit